|
JPS6023120B2
(ja)
|
1979-08-13 |
1985-06-05 |
キッコーマン株式会社 |
アデノシン−3′,5′−環状リン酸アルキルトリエステルの製造法
|
|
DE3027279A1
(de)
|
1980-07-18 |
1982-05-06 |
Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz |
Substituierte adenosin-3',5'-phosphorsaeurebenzyltriester, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
|
|
US4526988A
(en)
|
1983-03-10 |
1985-07-02 |
Eli Lilly And Company |
Difluoro antivirals and intermediate therefor
|
|
JPS61204193A
(ja)
|
1985-03-05 |
1986-09-10 |
Takeda Chem Ind Ltd |
シトシンヌクレオシド類の製造法
|
|
CA1327358C
(en)
|
1987-11-17 |
1994-03-01 |
Morio Fujiu |
Fluoro cytidine derivatives
|
|
JPH0692987A
(ja)
|
1992-09-17 |
1994-04-05 |
Tanabe Seiyaku Co Ltd |
ウリジン誘導体およびその製法
|
|
AU671491B2
(en)
|
1992-12-18 |
1996-08-29 |
F. Hoffmann-La Roche Ag |
N-oxycarbonyl substituted 5'-deoxy-5-fluorcytidines
|
|
US5693521A
(en)
|
1993-04-09 |
1997-12-02 |
The Regents Of The University Of California |
Membrane-permeant second messengers
|
|
US5834436A
(en)
|
1993-04-09 |
1998-11-10 |
The Regents Of The University Of California |
Membrane-permeant second messengers
|
|
US5866548A
(en)
|
1993-04-09 |
1999-02-02 |
The Regents Of The University Of California |
Caged membrane-permeant inositol phosphates
|
|
US5476932A
(en)
|
1994-08-26 |
1995-12-19 |
Hoffmann-La Roche Inc. |
Process for producing N4-acyl-5'-deoxy-5-fluorocytidine derivatives
|
|
US6312662B1
(en)
|
1998-03-06 |
2001-11-06 |
Metabasis Therapeutics, Inc. |
Prodrugs phosphorus-containing compounds
|
|
HRP20030047B1
(hr)
|
2000-07-21 |
2016-02-26 |
Gilead Sciences, Inc. |
Prolijekovi koji su fosfonatni analozi nukleotida i metode njihovog odabira te njihova priprava
|
|
CA2416527C
(en)
|
2000-08-10 |
2009-12-22 |
Pharmacia Italia S.P.A. |
Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
|
|
WO2002092006A2
(en)
|
2001-05-16 |
2002-11-21 |
Micrologix Biotech, Inc. |
Nucleic acid-based compounds and methods of use thereof
|
|
KR20050035194A
(ko)
|
2002-06-28 |
2005-04-15 |
이데닉스 (케이만) 리미티드 |
플라비비리다에 감염 치료용 2'-c-메틸-3'-o-l-발린에스테르 리보푸라노실 사이티딘
|
|
WO2005018330A1
(en)
|
2003-08-18 |
2005-03-03 |
Pharmasset, Inc. |
Dosing regimen for flaviviridae therapy
|
|
ES2310860T3
(es)
|
2004-12-17 |
2009-01-16 |
Eli Lilly And Company |
Profarmaco amida de gemcitabina, composiciones y uso del mismo.
|
|
WO2007027248A2
(en)
|
2005-05-16 |
2007-03-08 |
Valeant Research & Development |
3', 5' - cyclic nucleoside analogues for treatment of hcv
|
|
EP1915053A2
(en)
|
2005-08-12 |
2008-04-30 |
Merck & Co., Inc. |
Novel 2'-c-methyl and 4'-c-methyl nucleoside derivatives
|
|
ES2436404T3
(es)
|
2005-10-03 |
2013-12-30 |
University Health Network |
Inhibidores ODCasa para el tratamiento de malaria
|
|
JP2009531284A
(ja)
|
2006-02-06 |
2009-09-03 |
ドクター レディズ ラボラトリーズ リミテッド |
ゲムシタビンの調製
|
|
WO2007094135A1
(ja)
|
2006-02-15 |
2007-08-23 |
Gifu University |
オリゴヌクレオチド誘導体及びその利用
|
|
FR2907786B1
(fr)
|
2006-10-27 |
2009-09-18 |
Univ Grenoble 1 |
Thionucleosides et applications pharmaceutiques
|
|
US8338593B2
(en)
|
2006-07-07 |
2012-12-25 |
Gilead Sciences, Inc. |
Modulators of toll-like receptor 7
|
|
WO2008030373A2
(en)
|
2006-09-01 |
2008-03-13 |
University Of Georgia Research Foundation, Inc. |
L- oddc prodrugs for cancer
|
|
WO2008083465A1
(en)
|
2007-01-08 |
2008-07-17 |
University Health Network |
Pyrimidine derivatives as anticancer agents
|
|
WO2008144980A1
(fr)
|
2007-05-25 |
2008-12-04 |
Topharman Shanghai Co., Ltd. |
Procédé de préparation et intermédiaires de la capécitabine
|
|
US8741858B2
(en)
|
2007-09-21 |
2014-06-03 |
Zhongxu Ren |
Oligomer-nucleoside phosphate conjugates
|
|
WO2009061781A1
(en)
|
2007-11-07 |
2009-05-14 |
Schering Corporation |
Novel modulators of cell cycle checkpoints and their use in combination with checkpoint kinase inhibitors
|
|
KR101013312B1
(ko)
|
2007-11-19 |
2011-02-09 |
한미홀딩스 주식회사 |
카페시타빈의 제조방법 및 이에 사용되는 β-아노머가강화된 트리알킬카보네이트 화합물의 제조방법
|
|
WO2009082846A1
(fr)
|
2007-12-28 |
2009-07-09 |
Topharman Shanghai Co., Ltd. |
Dérivé hydroxyle de la capécitabine, ses procédés de préparation et ses utilisations pour préparer la capécitabine
|
|
EP2096114A1
(en)
|
2008-02-27 |
2009-09-02 |
Bayer CropScience AG |
Insecticidal Derivates of Substituted Phosphorylated Phenylalkyl Iminooxazolines and Iminothiazolines
|
|
US8173621B2
(en)
|
2008-06-11 |
2012-05-08 |
Gilead Pharmasset Llc |
Nucleoside cyclicphosphates
|
|
WO2010027326A1
(en)
|
2008-09-03 |
2010-03-11 |
Nanyang Technological University |
Peptide nucleic acid monomers and oligomers
|
|
EP2350296A4
(en)
|
2008-11-17 |
2013-04-03 |
Enzon Pharmaceuticals Inc |
BRANCHED CATIONIC LIPIDS FOR THE SYSTEM FOR INTRODUCING NUCLEIC ACIDS
|
|
EP2393472B1
(en)
|
2008-12-05 |
2019-06-05 |
NanoMed Holdings Pty Ltd |
Amphiphile prodrugs
|
|
AR074897A1
(es)
|
2008-12-23 |
2011-02-23 |
Pharmasset Inc |
Fosforamidatos de nucleosidos
|
|
CN101525361B
(zh)
|
2009-04-21 |
2010-11-17 |
济南圣鲁金药物技术开发有限公司 |
基于吉西他滨结构的前药及其合成方法及应用
|
|
CN101875680B
(zh)
|
2009-04-28 |
2012-07-25 |
上海信旗医药科技有限公司 |
一种核苷类化合物及其制备方法和应用
|
|
JO3027B1
(ar)
|
2009-05-14 |
2016-09-05 |
Janssen Products Lp |
نيوكليوسيدات يوراسيل سبيرواوكسيتان
|
|
CN101921303A
(zh)
|
2009-06-09 |
2010-12-22 |
曾慧慧 |
苯并异硒唑酮二氟胞苷类化合物及其制备方法和其用途
|
|
US8455451B2
(en)
|
2009-09-21 |
2013-06-04 |
Gilead Sciences, Inc. |
2'-fluoro substituted carba-nucleoside analogs for antiviral treatment
|
|
CN102939291B
(zh)
|
2010-04-14 |
2016-09-07 |
加利福尼亚大学董事会 |
用于病毒感染治疗的具有降低的毒性的膦酸酯
|
|
CN102351931B
(zh)
|
2010-09-07 |
2014-01-22 |
河南省科学院高新技术研究中心 |
嘧啶核苷衍生物、合成方法及其在制备抗肿瘤、抗病毒药物中的应用
|
|
US20120070411A1
(en)
|
2010-09-22 |
2012-03-22 |
Alios Biopharma, Inc. |
Substituted nucleotide analogs
|
|
US20120142627A1
(en)
|
2010-12-06 |
2012-06-07 |
Emory University |
Monophosphate prodrugs of dapd and analogs thereof
|
|
US8772474B2
(en)
|
2010-12-22 |
2014-07-08 |
Alios Biopharma, Inc. |
Cyclic nucleotide analogs
|
|
CN102219817A
(zh)
|
2011-04-12 |
2011-10-19 |
连云港杰瑞药业有限公司 |
活性偶联剂用于氟化嘧啶化合物烷氧羰酰化的方法
|
|
SI2827875T1
(sl)
|
2012-03-21 |
2019-04-30 |
Alios Biopharma, Inc. |
Substituirani nukleozidi, nukleotidi in njihovi analogi
|
|
WO2013177195A1
(en)
|
2012-05-22 |
2013-11-28 |
Idenix Pharmaceuticals, Inc. |
3',5'-cyclic phosphate prodrugs for hcv infection
|
|
PT2861611T
(pt)
|
2012-05-25 |
2016-10-11 |
Janssen Sciences Ireland Uc |
Nucleósidos de espirooxetano de uracilo
|
|
CN107312039B
(zh)
|
2012-08-30 |
2019-06-25 |
江苏豪森药业集团有限公司 |
一种替诺福韦前药的制备方法
|
|
WO2014043380A1
(en)
|
2012-09-14 |
2014-03-20 |
Ligand Pharmaceuticals Incorporated |
Novel nucleotide prodrug compounds and use
|
|
US9872919B2
(en)
|
2012-09-19 |
2018-01-23 |
The Research Foundation For The State University Of New York |
Prodrugs for selective anticancer therapy
|
|
ES2674980T3
(es)
|
2012-10-08 |
2018-07-05 |
Idenix Pharmaceuticals Llc |
Análogos de 2'-cloro nucleósidos para infección por VHC
|
|
EP2909209B1
(en)
|
2012-10-17 |
2022-08-03 |
Merck Sharp & Dohme LLC |
2'-cyano substituted nucleoside derivatives and methods of use thereof for treatment of viral diseases
|
|
US9227990B2
(en)
|
2012-10-29 |
2016-01-05 |
Cipla Limited |
Antiviral phosphonate analogues and process for preparation thereof
|
|
US9447137B2
(en)
|
2012-11-07 |
2016-09-20 |
Nucorion Pharmaceuticals, Inc. |
Substituted gemcitabine aryl amide analogs
|
|
JP2016501200A
(ja)
|
2012-11-19 |
2016-01-18 |
メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. |
ウイルス性疾患を処置するための2−アルキニル置換ヌクレオシド誘導体
|
|
US9243022B2
(en)
|
2012-12-21 |
2016-01-26 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
|
WO2014124430A1
(en)
|
2013-02-11 |
2014-08-14 |
Emory University |
Nucleotide and nucleoside therapeutic compositions and uses related thereto
|
|
WO2014145207A1
(en)
|
2013-03-15 |
2014-09-18 |
Ohio State Innovation Foundation |
Substituted gemcitabine bicyclic amide analogs and treatment methods using same
|
|
WO2014204831A1
(en)
|
2013-06-18 |
2014-12-24 |
Merck Sharp & Dohme Corp. |
Cyclic phosphonate substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
|
|
EP3074399A1
(en)
|
2013-11-27 |
2016-10-05 |
Idenix Pharmaceuticals LLC |
2'-dichloro and 2'-fluoro-2'-chloro nucleoside analogues for hcv infection
|
|
JP2017504572A
(ja)
|
2013-11-27 |
2017-02-09 |
アイデニクス・ファーマシューティカルズ・エルエルシー |
肝臓癌治療のためのヌクレオチド類
|
|
WO2015134334A1
(en)
|
2014-03-03 |
2015-09-11 |
Suo Zucai |
Gemcitabine analogs
|
|
EP3131914B1
(en)
|
2014-04-16 |
2023-05-10 |
Idenix Pharmaceuticals LLC |
3'-substituted methyl or alkynyl nucleosides for the treatment of hcv
|
|
AU2015265607A1
(en)
|
2014-05-28 |
2016-11-17 |
Idenix Pharmaceuticals Llc |
Nucleoside derivatives for the treatment of cancer
|
|
CN107295800A
(zh)
|
2015-02-25 |
2017-10-24 |
配体药物公司 |
吉西他滨衍生物
|
|
WO2017019581A1
(en)
|
2015-07-29 |
2017-02-02 |
Merck Sharp & Dohme Corp. |
Process for making phosphorus-containing nucleoside prodrug compounds
|
|
JP6743135B2
(ja)
|
2015-09-02 |
2020-08-19 |
アッヴィ・インコーポレイテッド |
抗ウィルス性テトラヒドロフラン誘導体
|
|
CN106554382B
(zh)
|
2015-09-29 |
2019-12-03 |
四川科伦博泰生物医药股份有限公司 |
核苷磷酰胺类化合物及其制备方法和药物中的应用
|
|
US20200179428A1
(en)
|
2016-06-20 |
2020-06-11 |
Merck Sharp & Dohme Corp. |
Cyclic phosphate substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
|
|
EP3471737B1
(en)
|
2016-06-20 |
2025-06-04 |
Merck Sharp & Dohme LLC |
Cyclic phosphate substituted nucleoside compounds and methods of use thereof for the treatment of viral diseases
|
|
US11364257B2
(en)
|
2016-06-24 |
2022-06-21 |
Emory University |
Phosphoramidates for the treatment of hepatitis B virus
|
|
CN106317116A
(zh)
|
2016-08-19 |
2017-01-11 |
张红利 |
磷酰胺核苷类化合物及其药学上可接受的盐与应用、药物组合物
|
|
US20190365788A1
(en)
|
2016-11-21 |
2019-12-05 |
Idenix Pharmaceuticals Llc |
Cyclic phosphate substituted nucleoside derivatives for the treatment of liver diseases
|
|
US10899786B2
(en)
|
2016-12-23 |
2021-01-26 |
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. |
Nucleoside phosphate compound and preparation method and use thereof
|
|
US10688112B2
(en)
|
2017-07-13 |
2020-06-23 |
Emory University |
Lipid disulfide prodrugs and uses related thereto
|
|
CN111491634A
(zh)
|
2017-07-31 |
2020-08-04 |
詹纽瑞治疗公司 |
有机磷酸酯衍生物
|
|
US10435429B2
(en)
|
2017-10-03 |
2019-10-08 |
Nucorion Pharmaceuticals, Inc. |
5-fluorouridine monophosphate cyclic triester compounds
|
|
CN109956986B
(zh)
|
2017-12-22 |
2021-04-27 |
浙江柏拉阿图医药科技有限公司 |
肝递送吉西他滨前体药物核苷环磷酸酯化合物及应用
|
|
AU2019207626B2
(en)
|
2018-01-10 |
2023-10-05 |
Nucorion Pharmaceuticals, Inc. |
Phosphor(n)amidatacetal and phosph(on)atalcetal compounds
|
|
CN111801339B
(zh)
|
2018-01-19 |
2025-06-24 |
纽科利制药公司 |
5-氟尿嘧啶化合物
|
|
US11427550B2
(en)
*
|
2018-01-19 |
2022-08-30 |
Nucorion Pharmaceuticals, Inc. |
5-fluorouracil compounds
|
|
AU2019227986A1
(en)
|
2018-03-02 |
2020-10-08 |
January Therapeutics, Inc. |
Nanoparticle compositions
|
|
WO2020154917A1
(en)
|
2019-01-29 |
2020-08-06 |
Minghui Pharmaceutical (Shanghai) Limited |
Phosphate and phosphonate based compounds of 6-thio-2'-deoxyguanosine as anti-cancer agents
|
|
MX428883B
(es)
|
2019-04-22 |
2025-11-13 |
Ligand Pharm Inc |
Compuestos ciclicos de fosfato
|
|
WO2020227132A1
(en)
|
2019-05-03 |
2020-11-12 |
Terns, Inc. |
Compounds for treating cancer
|
|
WO2021011692A1
(en)
|
2019-07-17 |
2021-01-21 |
Nucorion Pharmaceuticals, Inc. |
Cyclic deoxyribonucleotide compounds
|
|
EP4143199B1
(en)
*
|
2020-04-21 |
2025-11-19 |
Ligand Pharmaceuticals, Inc. |
Nucleotide prodrug compounds
|
|
WO2022086858A1
(en)
|
2020-10-19 |
2022-04-28 |
Aptinyx Inc. |
Methods of treating post-traumatic stress disorder and related conditions
|
|
JP7699205B2
(ja)
|
2020-10-21 |
2025-06-26 |
リガンド・ファーマシューティカルズ・インコーポレイテッド |
抗ウイルスプロドラッグ化合物
|
|
US20240294565A1
(en)
|
2021-05-17 |
2024-09-05 |
Ligand Pharmaceuticals Incorporated |
Unnatural configuration nucleotide prodrug compounds
|